Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial
- 26 January 2006
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 20 (4), 748-750
- https://doi.org/10.1038/sj.leu.2404122
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemiaLeukemia, 2004
- 6-Thioguanine, Cytarabine, and Daunorubicin (TAD) and High-Dose Cytarabine and Mitoxantrone (HAM) for Induction, TAD for Consolidation, and Either Prolonged Maintenance by Reduced Monthly TAD or TAD-HAM-TAD and One Course of Intensive Consolidation by Sequential HAM in Adult Patients at All Ages With De Novo Acute Myeloid Leukemia (AML): A Randomized Trial of the German AML Cooperative GroupJournal of Clinical Oncology, 2003
- Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trialBlood, 2001
- The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trialBlood, 2001
- Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabineBlood, 2001
- Acute Myeloid LeukemiaHematology-American Society Hematology Education Program, 2001
- Treatment of acute myelogenous leukemia in older adultsLeukemia, 2000